ExodusPoint Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
MC
WA
ExodusPoint Capital Management's RGEN Position: Q2 2026 in Review
ExodusPoint Capital Management reduced its Repligen (RGEN) stake by 89% in Q2 2026, selling an estimated $4.42M and leaving 4,288 shares worth $585K. The position accounts for ﹤0.01% of the portfolio, ranked #1197.
ExodusPoint Capital Management first reported a position in RGEN in Q2 2019 and has held it in 21 quarters since. The position peaked at $61.2M in Q2 2025. 482 funds tracked by Wall St. Rank hold RGEN as of Q2 2026.
- ExodusPoint Capital Management held 4,288 shares of Repligen worth $585K as of Q2 2026.
- ExodusPoint Capital Management sold 35,940 Repligen shares in Q2 2026, an estimated $4.42M.
- Repligen made up ﹤0.01% of ExodusPoint Capital Management's portfolio in Q2 2026, its #1197 holding.
- ExodusPoint Capital Management first reported a position in Repligen in Q2 2019 and has held it in 21 quarters since.
- ExodusPoint Capital Management's Repligen position peaked at $61.2M in Q2 2025.
- 482 funds tracked by Wall St. Rank held Repligen as of Q2 2026.
Based on ExodusPoint Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.